[89Zr]Zr-PSMA-617 PET/CT characterization of indeterminate [68Ga]Ga-PSMA-11 PET/CT findings in patients with biochemical recurrence of prostate cancer: lesion-based analysis

[89Zr]Zr-PSMA-617 PET/CT characterization of indeterminate [68Ga]Ga-PSMA-11 PET/CT findings in patients with biochemical recurrence of prostate cancer: lesion-based analysis

Abstract Background The state-of-the-art method for imaging men with biochemical recurrence of prostate cancer (BCR) is prostate-specific membrane antigen (PSMA)-targeted positron emission tomography/computed tomography (PET/CT) with tracers containing short-lived radionuclides, e.g., gallium-68 (68...

Full description

Bibliographic Details
Main Authors: Florian Rosar, Caroline Burgard, Elena Larsen, Fadi Khreish, Robert J. Marlowe, Andrea Schaefer-Schuler, Stephan Maus, Sven Petto, Mark Bartholomä, Samer Ezziddin
Format: Article
Language:English
Published: BMC 2024-02-01
Series:Cancer Imaging
Subjects:
Prostate cancer
Biochemical recurrence
Positron emission tomography/computed tomography (PET/CT)
Indeterminate findings
Prostate-specific membrane antigen (PSMA)
Zirconium-89 (89Zr)
Online Access:https://doi.org/10.1186/s40644-024-00671-1

Internet

https://doi.org/10.1186/s40644-024-00671-1

Similar Items